GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $528,000 | +30.7% | 12,128 | +32.4% | 0.27% | +14.5% |
| Q4 2021 | $404,000 | +18.8% | 9,163 | +3.1% | 0.24% | +51.6% |
| Q3 2021 | $340,000 | -2.3% | 8,888 | +1.8% | 0.16% | +2.0% |
| Q2 2021 | $348,000 | -35.9% | 8,728 | -42.7% | 0.15% | -34.8% |
| Q1 2021 | $543,000 | -8.0% | 15,228 | -5.0% | 0.23% | -15.3% |
| Q4 2020 | $590,000 | +0.9% | 16,028 | +3.1% | 0.28% | -19.8% |
| Q3 2020 | $585,000 | -13.3% | 15,548 | -6.0% | 0.34% | -19.5% |
| Q2 2020 | $675,000 | +10.3% | 16,548 | +2.5% | 0.43% | -4.1% |
| Q1 2020 | $612,000 | -22.0% | 16,148 | -3.4% | 0.44% | +18.1% |
| Q4 2019 | $785,000 | +26.2% | 16,714 | +14.8% | 0.38% | +9.0% |
| Q3 2019 | $622,000 | +18.3% | 14,564 | +10.7% | 0.34% | +12.7% |
| Q2 2019 | $526,000 | +17.9% | 13,153 | +23.3% | 0.31% | +11.7% |
| Q1 2019 | $446,000 | +25.3% | 10,669 | +14.4% | 0.27% | +5.8% |
| Q4 2018 | $356,000 | -9.9% | 9,329 | -5.0% | 0.26% | +0.4% |
| Q3 2018 | $395,000 | +24.2% | 9,821 | +24.6% | 0.26% | +8.9% |
| Q2 2018 | $318,000 | +7.4% | 7,881 | +4.1% | 0.24% | +4.9% |
| Q1 2018 | $296,000 | +15.2% | 7,571 | +4.3% | 0.23% | +19.6% |
| Q4 2017 | $257,000 | -14.9% | 7,257 | -2.6% | 0.19% | -21.9% |
| Q3 2017 | $302,000 | -8.5% | 7,447 | -2.6% | 0.24% | -11.4% |
| Q2 2017 | $330,000 | -10.3% | 7,647 | -12.5% | 0.27% | -13.9% |
| Q1 2017 | $368,000 | +15.0% | 8,737 | +5.2% | 0.32% | +16.1% |
| Q4 2016 | $320,000 | -8.6% | 8,309 | +2.5% | 0.27% | -7.8% |
| Q3 2016 | $350,000 | -4.6% | 8,107 | -4.2% | 0.30% | +33.9% |
| Q2 2016 | $367,000 | -2.9% | 8,464 | -9.1% | 0.22% | -9.1% |
| Q1 2016 | $378,000 | -45.5% | 9,314 | -45.8% | 0.24% | -38.5% |
| Q4 2015 | $693,000 | +65.0% | 17,177 | +57.4% | 0.40% | +43.1% |
| Q3 2015 | $420,000 | +2.2% | 10,916 | +10.8% | 0.28% | +15.0% |
| Q2 2015 | $411,000 | -50.2% | 9,856 | -62.2% | 0.24% | -52.2% |
| Q1 2015 | $826,000 | – | 26,049 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |